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1. Introduction 
The mechanism by which insulin exerts its acute 
effects on cell metabolism, such as glucose transport 
and the low-K, phosphodiesterase is still unknown. 
Lately, several interesting observations touching on 
this problem have been reported (review [l]). One of 
the discussed mechanisms includes a shifting of cal- 
cium within the different cellular pools under the 
influence of insulin [ 2-51. 
We have investigated insulin effects on glucose 
transport and metabolism in isolated fat cells of 
hypophysectomized (hypox) rats [6-L%]. We found a 
maximal glucose transport rate in the basal state and 
a lack of further effects of insulin. In contrast, glu- 
cose incorporation into lipids of these cells was 
decreased but was also insulin-insensitive [6]. The 
lipid synthesizing capacity was normalized after treat- 
ment of the hypox rats for several days with ACTH 
together with T3 [7]. The glucose-transport system 
was restored after chronic administration of growth 
hormone (GH) alone to hypox rats [7]: basal glucose- 
transport rate was decreased to normal and could 
again be acutely stimulated by insulin. We therefore 
suggested a GH-dependent ‘limiting factor’ in the fat 
cell membrane, which inhibits the glucose-transport 
system in the basal state. Insulin would release the 
brakes and enhance the glucose transport [7,8]. 
Furthermore, we have shown that the activity of insu- 
lin-sensitive, low-K, phosphodiesterase is also increas- 
ed in fat cells of hypox rats, insensitive to insulin and 
that growth hormone treatment reverses these altera- 
tions so that the same ‘limiting membrane factor’ 
may be responsible [9,1 I]. 
To learn more about this growth hormone-depen- 
dent ‘limiting factor’ we investigated the low-K, 
Ca”-ATPase in the fat cell membrane of normal, 
hypox and GH-treated hypox rats. This Ca”-ATPase 
in purified fat cell plasma membranes has been char- 
acterized [lo] and reported to be acutely inhibited 
by insulin [5]. Here, we show a drastic decrease of 
the activity and a loss of the insulin-sensitivity of the 
Ca2+-ATPase after hypophysectomy and their norma- 
lization by GH-treatment. 
2. Materials and methods 
Male Sprague Dawley (Tif RAI) rats (8-l 6) weigh- 
ing between 120 and 160 g were used for each experi- 
ment. Hypox rats and their normal litter-mates were 
kindly supplied by Dr.Maier and Mr Meier, Ciba 
Geigy, Base]. 
Hypophysectomy was done 3- 10 weeks before 
the experiments. Growth hormone was substituted 
as in [ 1 I]. Human GH (200 mu/day and rat) was 
injected intraperitoneally for 6 days. 
Plasma membranes were purified as in [ 121. EDTA 
was omitted from the fractionation medium [ 131. 
The low-K, Ca2+-ATPase was assayed as in [5]. 
Purified plasma membranes (IO-30 pg/ml) were 
incubated for 10 min in Tris-Pipes buffer [ 12.5 mM, 
pH 7.4,37”C containing NaN, (20 mM), EGTA (200 
PM), CaC12 (100-200 PM) and [-Y-~~P]ATP (1 mM)]. 
The incubation volume was 500 ~1. The reaction was 
stopped by the addition of sodium dodecylsulfate 
(6 mg/lOO ~1) and hydrolyzed 32P was extracted and 
assayed as in [ 141. The protein content was deter- 
mined as in [ 151. Free Ca2* was calculated [lo] using 
the affinity constants in [ 161. 
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[r-“‘PI ATP was from the Radiochemical Centre. 
Amersham. All chemicals were from Fluka. Buchs. 
Human growth hormone was a gift from Serono. 
Rome. Whale insulin (identical amino acid sequence 
to pork insulin) was kindly provided by Dr R. E. 
Humbel. 
3. Results 
A high-affinity Ca2+-dependent ATPase was shown 
to exist in the fat cell membranes [S]. This enzyme 
is inhibited by insulin. 
The discovery of an insulin-suppressible Ca2+- 
ATPase in the membrane of fat cells appeared relevant 
for our model of insulin action on glucose transport 
and phosphodiesterase activity in hypox and GH- 
treated hypox rats [6,8], where we had postulated a 
growth hormone-dependent ‘limiting factor’ on the 
fat cell membrane, that itself is acutely inhibited by 
insulin. The interaction of insulin with this ‘limiting 
factor’ would result in an increased activity of the 
glucose transport [7] and of the low-K, phospho- 
diesterase [9,11]. 
As shown in fig. 1, insulin also inhibits the activity 
of the high affinity Ca*+-ATPase in purified plasma 
membranes of fat cells of normal rats. Addition of 
insulin to the membrane preparation inhibits the 
activity by -50%. The half-maximal inhibition was 
achieved at 1.1 X IO-” M of insulin corresponding 
rather well to the insulin concentration required for 
half-maximal stimulation of glucose transport. These 
results agree well with [5]. In fat-cell membranes 
from hypox rats we found a marked decrease of the 
basal activity of Ca”-ATPase and insulin was without 
effect. The basal activity was only 40% of that of 
normal rats. After administration of 200 mU growth 
hormone/day for 6 days, the basal activity of the 
Ca’+-ATPase returned towards normal. It was 88% as 
active as in normal fat cell membranes and became 
again inhibitory (fig.1). 
The dependence of the high-affinity Ca”-ATPase 
on the concentration of free Ca2+ is shown in fig.2. 
The half-saturation constant of the low-K, Ca’+- 
ATPase for Ca*+ (KO,s) was 0.16 /.LM in adipocyte 
membranes from normal rats: this agreeing with [51. 
The K,., value was not changed after hypophy- 
sectomy. It was 0.15 I.IM both in hypox and in GH- 
treated hypox rats. 
The V,, of the high-affinity Ca”-ATPase was 
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Fig.1. Insulin inhibition of a high affinity Ca*‘-ATPase in fat 
cell membranes of normal, hypophysectomized and growth 
hormone-treated hypophysectomized rats. Free Ca’+ was 47 
nM. The Ca*‘-ATPase was measured as described in the text. 
Insulin was added from a human serum albumin (HSA) con- 
taining stock solution 171. The final HSA concentration was 
10 mg/l in each sample, also in the absence of insulin. Cell 
membranes were prepared from (o) normal, (0) hypox and 
(A) growth hormone-treated hypox rats. Each point repre- 
sents the mean f SEM of 2-6 expt. carried out in duplicates. 
I, I 
Fig.2. Ca2+dependence of the high-affinity CaZ+-ATPase in 
fat cell membranes of normal (o), hypox (e) and GH-treated 
hypox rats (A). HSA was omitted. Each point represents the 
mean * SEM of the results from different membrane prepara- 
tions. n = 6 for normal and for hypox rats, and 3 for GH-treated 
hypox rats. 
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decreased after hypophysectomy and restored towards 
normal after GH-administration. 
In fat cell membranes of normal rats the Vmax was 
98.3 nmol . mg-r . min-‘, in hypox rats 55.7 nmol . 
mg-’ . min-’ and in GH-treated hypox rats 85.2 
nmol . mg-’ . min-‘. The decrease of the high-affinity 
Ca*‘-ATPase remains unchanged between 3 and 10 
weeks after hypophysectomy. 
In contrast to the Ca*+-ATPase, the activity of the 
5’-nucleotidase in the plasma membrane fraction 
remained unchanged for at least 4 weeks after hypo- 
physectomy. The loss of activity which occurred 
afterwards was not restored after GII-administration 
(not shown). 
It has been suggested [5] that the high-affinity 
Ca*+-ATPase of isolated fat cells may be an early 
metabolic step influenced by insulin which regulates 
intracellular Ca*‘-levels. Our data strongly support 
this contention. They are even compatible with the 
hypothesis that the high affinity Ca*+-ATPase might 
represent the proposed growth hormone-dependent 
‘limiting factor’ [7,8] in the fat cell membrane. 
It could explain the maximal and insulin-insensitive 
activities of the glucose-transport system [6] and the 
low-K, phosphodiesterase [9,1 l] in fat cells ofhypox 
rats and their normalization after CT-I-treatment. 
If this Ca’+-ATPase represents a Ca*+ extrusion 
pump in the fat cell membrane, the inhibition of its 
activity would cause an increase of intracellular Ca*+ 
pools. Increased cytoplasmic calcium may be involved 
in the regulation of insulin-sensitive metabolic steps, 
such as the glucose transport through the plasma 
membrane [2], the low-K, phosphodiesterase activ- 
ity, which is not stimulated by insulin in the presence 
of EGTA [ 171, and also pyruvate dehydrogenase 
activity [ 181. 
However, it is unlikely that the inhibition of the 
CT&dependent high affinity Ca*‘-ATPase, by which 
insulin could control cytoplasmic calcium levels, is 
responsible for all short-time insulin effects in fat 
cells. Rather, Ca*+ may be involved, possibly as the 
limiting step in various insulin-sensitive systems, such 
as the generation of a mediator protein [ 19-2 I] or 
the translocation of a glucose transport system from 
the cytoplasma to the plasma membrane [22,23]. A 
more thorough experimental approach to these ques- 
tions may eventually lead to the understanding of the 
links between calcium, other cytoplasmic factors and 
insulin action. 
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